This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Demetrix, Inc.. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Jeff Ubersax: Innovator in Cannabinoid Synthesis
Introduction
Jeff Ubersax is a prominent inventor based in San Francisco, CA. He has made significant contributions to the field of cannabinoid synthesis, particularly through his innovative work at Demetrix, Inc. His expertise in this area has led to the development of advanced technologies that enhance cannabinoid production.
Latest Patents
Ubersax holds a patent for "Optimized cannabinoid synthase polypeptides." This patent provides engineered variants of a cannabidiolic acid synthase (CBDAS) polypeptide, which includes an amino acid sequence with specific substitutions. The patent also covers nucleic acids that encode these engineered variants, methods for creating modified host cells, and techniques for producing cannabinoids or cannabinoid derivatives.
Career Highlights
Throughout his career, Ubersax has focused on the intersection of biotechnology and cannabinoid research. His work has not only advanced scientific understanding but has also paved the way for practical applications in the cannabis industry. His innovative approach has garnered attention and respect within the scientific community.
Collaborations
Ubersax collaborates with talented individuals such as Andrew Horwitz and Jeff Wong. These partnerships have fostered a creative environment that encourages the exploration of new ideas and technologies in cannabinoid synthesis.
Conclusion
Jeff Ubersax is a key figure in the field of cannabinoid synthesis, with a patent that showcases his innovative contributions. His work at Demetrix, Inc. continues to influence the industry and drive advancements in cannabinoid production.